U.S. flag

An official website of the United States government

GTR Home > Genes

SPAST spastin

Gene ID: 6683, updated on 2-Nov-2024
Gene type: protein coding
Also known as: FSP2; SPG4; ADPSP

Summary

This gene encodes a member of the AAA (ATPases associated with a variety of cellular activities) protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The use of alternative translational initiation sites in this gene results in a single transcript variant that can produce isoforms that differ in the length of their N-terminus and which thereby differ in the efficiency of their export from the nucleus to the cytoplasm. In addition, alternative splicing results in multiple transcript variants that encode isoforms that differ in other protein regions as well. One isoform of this gene has been shown to be a microtubule-severing enzyme that regulates microtubule abundance, mobility, and plus-end distribution. Mutations in this gene cause the most frequent form of autosomal dominant spastic paraplegia 4. [provided by RefSeq, May 2018]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
Hereditary spastic paraplegia 4
MedGen: C1866855OMIM: 182601GeneReviews: Spastic Paraplegia 4
See labs
Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults.
GeneReviews: Not available

Copy number response

Description
Copy number response
Triplosensitivity

No evidence available (Last evaluated 2019-09-25)

ClinGen Genome Curation Page
Haploinsufficency

Sufficient evidence for dosage pathogenicity (Last evaluated 2019-09-25)

ClinGen Genome Curation PagePubMed

Genomic context

Location:
2p22.3
Sequence:
Chromosome: 2; NC_000002.12 (32063556..32157637)
Total number of exons:
17

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.